Literature DB >> 34746514

Acceptance of COVID-19 vaccination and correlated variables among global populations: A systematic review and meta-analysis.

Ricvan Dana Nindrea1, Elly Usman2, Yusticia Katar2, Nissa Prima Sari3.   

Abstract

INTRODUCTION: The most awaited solution is an efficient COVID-19 vaccine. COVID-19 vaccine acceptance has not been studied in a meta-analysis. The objective of this research was to find the acceptance of COVID-19 vaccination and correlated variables.
METHODS: A systematic review of studies on acceptance of COVID-19 vaccination and correlated variables in the ProQuest, PubMed, and EBSCO to find relevant articles published between January 2020 and March 2021. Using fixed and random-effect models, the risk factors Pooled Odds Ratio (POR) were measured. The heterogeneity was calculated using the I-squared formula. Egger's and Begg's tests were utilised to determine publication bias. STATA 16.0 was used for all data processing and analysis.
RESULTS: This study results showed the related factors for COVID-19 vaccination acceptance, high income has the highest odd ratio (POR = 2.36), followed by encountered with COVID-19 (POR = 2.34), fear about COVID-19 (POR = 2.07), perceived benefits (POR = 1.81), flu vaccine during the previous season (POR = 1.69), healtcare workers (POR = 1.62), male (POR = 1.61), married (POR = 1.59), perceived risk (POR = 1.52), trust in health system (POR = 1.52), chronic diseases (POR = 1.47), high education (POR = 1.46), high level of knowledge (POR = 1.39), female (1.39), and older age (POR = 1.07). The heterogeneity calculation showed homogenous among studies in high income, fear about COVID-19, healthcare workers, married, chronic diseases, and female (I2 ≤ 50%). For the studies included in this review, there was no apparent publication bias.
CONCLUSION: The analysis of this review may be useful to the nation in determining the best method for implementing COVID-19 mass vaccination programs based on relevant factors that influence vaccine acceptance.
© 2021 The Authors.

Entities:  

Keywords:  Acceptance; COVID-19; Risk factors; Vaccine

Year:  2021        PMID: 34746514      PMCID: PMC8559452          DOI: 10.1016/j.cegh.2021.100899

Source DB:  PubMed          Journal:  Clin Epidemiol Glob Health        ISSN: 2213-3984


Introduction

Since 2020, COVID-19 widespread has become a serious community health concern. The COVID-19 emergency afflicted many nations. By March 2021, there had been over 128.2 million confirmed cases of the disease, with 2.8 million deaths. COVID-19 not only has a major health effect, but it also has a significant economic impact that should not be ignored. It has resulted in a major decline in workforces and an increase in jobless around the world. These negative consequences have prompted pharmaceutical firms to produce a vaccine as soon as possible. At the end of 2020, multiple vaccines to prevent COVID-19 infection were approved. and there were more than fifty COVID-19 vaccine potential in production. Vaccination programs have started in a number of countries around the world. Despite this, people continue to have concerns about vaccine safety and effectiveness, including the durability of COVID-19 defense, as many cases of reinfection have been documented. , Furthermore, the rapid production of vaccines raises concerns about their efficacy. Vaccine production has historically been connected to harmful effects. For decades, vaccines have proven to be an effective means of disease prevention. Vaccine hesitancy and refusal, on the other hand, are major issues around the world, causing the World Health Organization (WHO) to name this confusion as one of the top ten health risks for 2019. Vaccine apprehension has been linked to religious values, personal opinions, and safety issues based on widespread misconceptions, such as the connection between vaccines and autism, brain injury, and other disorders, according to various reports. Regrettably, there have been inadequate research undertaken in order to determine the global population's attitudes toward vaccination. No previously published work has been analyzed by meta-analysis to our knowledge. The findings of this study may help the government figure out the important way to execute COVID-19 mass vaccination programs.

Materials and methods

Study design and research sample

To assess current articles related to the acceptance of COVID-19 vaccination and correlated variables, a systematic review and meta-analysis studies were conducted. The preferred reporting items for systematic reviews and meta-analyses (PRISMA) guideline was followed in this study. There are three databases, i.e. ProQuest, PubMed, and EBSCO were used to search for relevant articles published between January 2020 and March 2021. In this research, the acceptance of COVID-19 vaccine was the dependent variable. The independent variables were the determinant factors of COVID-19 vaccine acceptance.

Research procedure

The keywords used to search related articles in ProQuest, PubMed, and EBSCO between January 2020 and March 2021 were: COVID-19 OR Coronavirus AND Vaccine AND Acceptance. The included articles limited to original or research articles, with English texts and with human as study subjects. The inclusion criteria included study on the acceptance of COVID-19 vaccine and related factors with study design of cross sectional. The study exclusion criteria included full text version is unavailable, unrelated topics or subjects, and data in publications that could not be extracted or used for further review. The Newcastle-Ottawa Quality Assessment Scale (NOS) modified for cross-sectional study was used to evaluate the articles' quality. 0–3, 4–6, and 7–9 were used to categorize articles into poor, medium, and high quality categories. The PRISMA flowcharts were used to illustrate the steps involved in finding research articles (Fig. 1 ).
Fig. 1

The PRISMA flowcharts.

The PRISMA flowcharts.

Data analysis

For further data analysis, the Pooled Odds Ratio (POR) of the effect size of each risk factor from the derived data was determined with a confidence degree of 95%. The heterogeneity was calculated using the I formula, and I> 50% indicated that there was heterogeneity between studies. If the result was heterogeneous, the random effect model was used, and if the result was homogeneous, the fixed effect model was used. Furthermore, the findings were viewed as forest plots, and publication bias was assessed using Egger's and Begg's tests. The p > 0.05 results from the two tests revealed that there was no publication bias among the studies. For lower middle income countries (LMICs), restricted-maximum likelihood random effects meta-regression was used to examine the role of covariate. STATA 16.0 was used for all data processing and analysis.

Results

This systematic review study included 24 recent studies conducted to the acceptance of COVID-19 vaccination and related factors (Table 1 ). The total sample from the included studies was 56,913 participants.13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
Table 1

Systematic review of COVID-19 vaccination acceptance and correlated variables among global populations.

First author, yearYear of studyRegionStudy designTotal samplesDeterminant factors (OR, 95% CI)NOS
Al-Qerem et al.132021Middle EasternCross sectional1,144Older age (2.42, 1.22–4.79)High level of knowledge (1.50, 1.38–1.62)7
Caserotti et al.142021ItalyCross sectional2,267Perceived risk (4.86, 3.53–6.74)Older age (1.47, 1.14–1.89)7
Ditekemena et al.152021Republic of CongoCross sectional4,131High income (2.31, 1.85–2.88)High education (1.82, 1.55–2.13)Perceived risk (7.78, 5.75–10.53)Chronic disease (1.26, 1.04–1.53)6
Seale et al.162021AustraliaCross sectional1,420Female (1.40, 1.10–1.80)Older age (3.10, 1.80–5.30)Chronic disease (1.40, 1.10–2.0)7
Sallam et al.172021Jordan, Kuwait, Saudi ArabiaCross sectional (online questionnaire)3,414Male (1.54, 1.28–1.85)Chronic disease (1.55, 1.15–2.09)7
Qattan et al.182021Saudi ArabiaCross sectional736Older age (2.22, 0.96–5.17)Male (1.61, 0.97–2.67)7
Saied et al.192021EgyptCross sectional2,133Healthcare workers (2.26, 1.34–3.81)7
Alley et al.202021AustraliaCross sectional2,343Female (1.89, 1.20–2.97)Chronic disease (1.39, 0.98–1.97)7
Wong et al.212021HongkongA population-based survey1,200Older age (2.03, 1.48–2.77)Chronic disease (1.89, 1.50–2.38)Perceived risk (1.09, 1.00–1.17)Perceived benefits of vaccination (1.79, 1.59–1.99)Trust in health system (1.36, 1.25–1.48)7
Alqudeimat et al.222021KuwaitCross sectional2,368Encountered with confirmed COVID-19 (5.67, 4.14–7.77)Flu vaccine during the previous season (1.35, 1.24–1.47)6
Gagneux- Brunon et al. et al.232021FrenchCross sectional1,554Male (2.21, 1.69–2.90)Older age (3.45, 1.53–7.77)Flu vaccine during the previous season (7.22, 5.68–9.19)Fear about COVID-19 (2.03, 1.58–2.61)Perceived risk (2.09, 1.70–2.57)6
Wang et al. (a)242021HongkongCross sectional2,047Married (1.69, 1.33–2.14)Flu vaccine during the previous season (2.25, 1.74–2.93)7
Verger et al.252021FranceCross sectional2,678Female (1.22, 0.96–1.55)Perceived risk (3.01, 2.38–3.79)Perceived benefits of vaccination (1.57, 1.05–2.36)5
Nzaji et al.262020Republic of CongoCross sectional613Married (1.25, 0.85–1.83)Healtcare workers (1.92, 1.31–2.81)Encountered with confirmed COVID-19 (8.83, 1.18–66.04)7
Lazarus et al.272020Global (19 countries)Cross sectional13,426Older age (1.73, 1.48–2.02)High education (1.34, 1.21–1.48)Trust in health system (1.67, 1.54–1.80)5
Detoc et al.282020FranceCross sectional (online survey)3,259Male (1.71, 1.42–2.06)Older age (2.25, 1.76–2.87)Healthcare workers (1.57, 1.33–1.86)Fear about COVID-19 (2.09, 1.75–2.49)Perceived risk (1.83, 1.54–2.16)6
Bell et al.292020EnglandCross sectional1,252High income (2.53, 1.67–3.83)6
Wang et al. (b)302020Hongkong, ChinaCross sectional806Male (2.78, 1.69–4.58)Encountered with confirmed COVID-19 (1.63, 1.14–2.33)Flu vaccine during the previous season (2.03, 1.47–2.81)7
Al-Mohaithef et al.312020Saudi ArabiaCross sectional (web survey)992Married (1.57, 1.20–2.06)Perceived risk (2.48, 1.11–3.95)Trust in the health system (2.85, 1.03–4.80)7
Harapan et al.322020IndonesiaCross sectional1,359Female (1.55, 1.01–2.38)Older age (2.10, 1.04–4.23)Healthcare workers (1.43, 1.06–1.93)7
Lin et al.332020ChinaCross sectional3,541Perceived benefits of vaccination (3.14, 2.05–4.83)Encountered with confirmed COVID-19 (1.65, 1.31–2.09)7
Malik et al.342020U·SCross sectional672Older age (1.81, 0.99–3.29)5
Sherman et al.352020UKCross sectional1,500Older age (1.04, 0.99–1.04)Perceived risk (1.03, 0.85–1.81)High level of knowledge (1.08, 1.04–1.39)7
Wang et al. (c)362020ChinaCross sectional2,058Male (1.25, 1.03–1.52)Married (1.70, 1.26–2.29)Perceived benefits of vaccination (1.56, 1.08–2.25)5
Total samples56,913

Abbreviation: CI = confidence interval; OR = odds ratio; NOS, Newcastle–Ottawa Quality Assessment Scale.

Systematic review of COVID-19 vaccination acceptance and correlated variables among global populations. Abbreviation: CI = confidence interval; OR = odds ratio; NOS, Newcastle–Ottawa Quality Assessment Scale. Table 1 is based on a synthesis of studies correlated variables for acceptance of COVID-19 vaccination, including 24 cross sectional studies. This study found factors contributing to acceptance of COVID-19 vaccination included older age, male, female, married, high education, high income, healthcare workers, chronic diseases, high level of knowledge, perceived risk, perceived benefits, fear about COVID-19, encountered with COVID-19, flu vaccine during the previous season and trust in health system. Meta-estimate of COVID-19 vaccination acceptance and correlated variables among global populations (Table 2 and Fig. 2 ). Table 2 and Fig. 2 showed high income has the highest Pooled Odds Ratio (POR, 95% CI) (2.36, 1.94–2.87), followed by encountered with COVID-19 (2.34, 1.98–2.76), fear about COVID-19 (2.07, 1.79–2.39), perceived benefits (1.81, 1.61–2.00), flu vaccine during the previous season (1.69, 1.57–1.82), healthcare workers (1.62, 1.42–1.85), male (1.61, 1.47–1.78), married (1.59, 1.38–1.83), perceived risk (1.52, 1.43–1.62), trust in health system (1.52, 1.44–1.61), chronic diseases (1.47, 1.31–1.65]), and high education (1.46, 1.34–1.59), high level of knowledge (1.39, 1.29–1.49), female (1.39, 1.19–1.61]), and older age (1.07, 1.05–1.10) with COVID-19 vaccination acceptance. The heterogeneity calculation showed homogenous among studies in high income, fear about COVID-19, healthcare workers, married, chronic diseases, and female (I ≤ 50%).
Table 2

Meta-estimate of COVID-19 vaccination acceptance and correlated variables among global populations.

Related factorsFirst authorOR (95% CI)POR (95% CI)Heterogeneity
I2 (%)p
Older Age1.07 (1.05–1.10)92.7<0.001

Al-Qerem et al.132.42 (1.22–4.79)
Caserotti et al.141.47 (1.14–1.89)
Seale et al.163.10 (1.80–5.30)
Qattan et al.182.22 (0.96–5.17)
Wong et al.212.03 (1.48–2.77)
Gagneux- Brunon et al.233.45 (1.53–7.77)
Lazarus et al.271.73 (1.48–2.02)
Detoc et al.282.25 (1.76–2.87)
Harapan et al.322.10 (1.04–4.23)
Malik et al.341.81 (0.99–3.29)
Sherman et al.351.04 (0.99–1.04)
Male1.61 (1.47-1.78)70.60.004
Sallam et al.171.54 (1.28–1.85)
Qattan et al.181.61 (0.97–2.67)
Gagneux- Brunon et al.232.21 (1.69–2.90)
Detoc et al.281.71 (1.42–2.06)
Wang et al. (b)302.78 (1.69–4.58)
Wang et al. (c)361.25 (1.03–1.52)
Female1.39 (1.19-1.61)5.00.358
Seale et al.161.40 (1.10–1.80)
Alley et al.201.89 (1.20–2.97)
Verger et al.251.22 (0.96–1.55)
Harapan et al.321.55 (1.01–2.38)
Married1.59 (1.38-1.83)00.579
Wang et al. (a)241.69 (1.33–2.14)
Nzaji et al.261.25 (0.85–1.83)
Al-Mohaithef et al.311.57 (1.20–2.06)
Wang et al. (c)361.70 (1.26–2.29)
High education1.46 (1.34-1.59)90.20.001
Ditekemena et al.151.82 (1.55–2.13)
Lazarus et al.271.34 (1.21–1.48)
High income2.36 (1.94-2.87)00.705
Ditekemena et al.152.31 (1.85–2.88)
Bell et al.292.53 (1.67–3.83)
Healthcare workers1.62 (1.42-1.85)3.90.373
Saied et al.192.26 (1.34–3.81)
Nzaji et al.261.92 (1.31–2.81)
Detoc et al.281.57 (1.33–1.86)
Harapan et al.321.43 (1.06–1.93)
Chronic disease1.47 (1.31-1.65)45.40.120
Ditekemena et al.151.26 (1.04–1.53)
Seale et al.161.40 (1.10–2.000
Sallam et al.171.55 (1.15–2.09)
Alley et al.201.39 (0.98–1.97)
Wong et al.211.89 (1.50–2.38)
High level of knowledge1.39 (1.29-1.49)93.4<0.001
Al-Qerem et al.131.50 (1.38–1.62)
Sherman et al.351.08 (1.04–1.39)
Perceived risk1.52 (1.43-1.62)97.5<0.001
Caserotti et al.144.86 (3.53–6.74)
Ditekemena et al.157.78 (5.75–10.53)
Wong et al.211.09 (1.00–1.17)
Gagneux- Brunon et al.232.09 (1.70–2.57)
Verger et al.253.01 (2.38–3.79)
Detoc et al.281.83 (1.54–2.16)
Al-Mohaithef et al.312.48 (1.11–3.95)
Sherman et al.351.03 (0.85–1.81)
Perceived benefits1.81 (1.64-2.00)59.90.058
Wong et al.211.79 (1.59–1.99)
Verger et al.251.57 (1.05–2.36)
Lin et al.333.14 (2.05–4.83)
Wang et al. (c)361.56 (1.08–2.25)
Fear about COVID-192.07 (1.79-2.39)00.852
Gagneux- Brunon et al.232.03 (1.58–2.61)
Detoc et al.282.09 (1.75–2.49)
Encountered with COVID-192.34 (1.98-2.76)93.3<0.001
Alqudeimat et al.225.67 (4.14–7.77)
Nzaji et al.268.83 (1.18–66.04)
Wang et al. (b)301.63 (1.14–2.33)
Lin et al.331.65 (1.31–2.09)
Flu vaccine during the previous season1.69 (1.57-1.82)98.3<0.001
Alqudeimat et al.221.35 (1.24–1.47)
Gagneux- Brunon et al.237.22 (5.68–9.19)
Wang et al. (a)242.25 (1.74–2.93)
Wang et al. (b)302.03 (1.47–2.81)
Trust in health system1.52 (1.44-1.61)86.50.001
Wong et al.211.36 (1.25–1.48)
Lazarus et al.271.67 (1.54–1.80)
Al-Mohaithef et al.312.85 (1.03–4.80)

Abbreviation: CI = confidence interval; OR = odds ratio; POR= Pooled odds ratio; I> 50%, heterogeneity.

Fig. 2

Forest plots of COVID-19 vaccination acceptance and correlated variables among global populations.

Meta-estimate of COVID-19 vaccination acceptance and correlated variables among global populations. Abbreviation: CI = confidence interval; OR = odds ratio; POR= Pooled odds ratio; I> 50%, heterogeneity. Forest plots of COVID-19 vaccination acceptance and correlated variables among global populations. The results of Egger's and Begg's test to assess bias among studies included (Table 3 ). Table 3 showed that based on Egger's and Begg's test result (p > 0.05), related factors of older age, male, female, married, high education, high income, healthcare workers, chronic diseases, high level of knowledge, perceived risk, perceived benefits, fear about COVID-19, encountered with COVID-19, flu vaccine during the previous season and trust in health system had no publication bias among studies combined.
Table 3

The results of Egger's and Begg's test to assess bias among studies included.

Related factorsStudy bias
Egger's testBegg's test
Older age0.9250.139
Male0.2690.573
Female0.1370.052
Married0.1590.174
High education0.1120.317
Low income0.1150.317
Healthcare workers0.3040.174
Chronic diseases0.8041.000
High level of knowledge0.8110.317
Perceived risk0.5770.458
Perceived benefits0.7400.497
Fear about COVID-190.1600.227
Encountered with COVID-190.0510.174
Flu vaccine during the previous season0.2801.000
Trust in health system0.7670.602

p > 0.05, no publication bias.

The results of Egger's and Begg's test to assess bias among studies included. p > 0.05, no publication bias. The association between LMICs and COVID-19 vaccine acceptance based on meta-regression (Fig. 3 ). Fig. 3 showed that the association between LMICs and decreased COVID-19 vaccine acceptance (p = 0.02). This analysis confirmed the COVID-19 vaccine acceptance may vary across these country types.
Fig. 3

The association between LMICs and COVID-19 vaccine acceptance based on meta-regression.

The association between LMICs and COVID-19 vaccine acceptance based on meta-regression.

Discussion

Our results found high income had high acceptance of COVID-19 vaccination. The acceptance rate rises with economic status. A study highlighted the importance of community confidence in vaccine uptake and found a scarcity of studies in low and middle-income households on vaccine uptake based on community trust. A higher willingness to receive COVID-19 vaccination was correlated with a higher income level, likely due to better access to high-quality information, such as through better television channels and/or through communication with people living abroad in COVID-19-affected countries, and/or because such people tend to live in towns where the virus is more prevalent. Encountered with COVID-19, fear of COVID-19 and perceived risk have found to be positively correlated with vaccine acceptance in this study. Previous studies in Asia have shown that a positive attitude toward vaccination is linked to a perception of risk or fear about COVID-19.38, 39, 40 Another study showed that a high perceived risk was related to COVID-19 vaccine acceptance among Saudi Arabian community members and Congo healthcare staff. , As a consequence, it is crucial to boost community expectations of risk. Low risk perception can be linked to vaccine acceptance, as well as social distancing and other community health defensive measures. These associations may be complicated; for example, a person who practices social distancing strategies can believe their risk is low but still wants to get vaccinated. Vaccination intention is strongly influenced by perceived benefits. Perceived advantages have been found to be determinant factors in some studies. , In the context of vaccination, perceived benefits are characterized as a person's attitudes toward vaccination. It's important to have public health intervention programs that concentrate on changing people's perceptions of vaccination's benefits while also removing the obstacles that have been identified. According to the findings of this report, there is a correlation between influenza vaccination during the past season and COVID-19 vaccination acceptance. Related positively flu vaccination during the past season to COVID-19 vaccine acceptance. , COVID-19 and seasonal influenza are likely to co-circulate during the winter of 2020–2021. Healthcare staff in France are advised to get vaccinated for the flu season. Patients with concomitant flu and COVID-19 can have poorer outcomes than patients with COVID-19 alone, so lowering the risk of coinfections in susceptible patients is important. Healthcare staff were more enthusiastic about a COVID-19 vaccine than non-healthcare staff, according to our results. In previous research, self-protection and a willingness to protect families, friends, and patients were the driving factors behind healthcare staff getting vaccinated. , Since healthcare staff have a more in-depth understanding of COVID-19, they will be more likely to protect themselves and not spread the virus to their family members. As a result, they could be more likely to consider the vaccine than those who work in non-medical fields. Sex and married were also found to be positively correlated with vaccine acceptance in this study. Previous studies have shown that men, women, and married people are more likely to support immediate pandemic vaccination. , , This may be due to everyone at risk in the gender group and marital status. Older people agreed to be vaccinated in our report. This may be because the belief that older adults and people with severe comorbidities or chronic diseases are more vulnerable to COVID-19's negative effects can cause a lot of anxiety among the elderly. Individuals with university/higher levels of education recorded having a substantially higher level of knowledge about COVID-19 vaccine acceptance. Related scenarios were observed in previous studies, showing that people with a higher educational experience learned more about COVID-19. , It's likely that more informed people are more aware of and caring about their health and well-being as a result of improved access to more media sources, as well as becoming more interested in life activities that may affect them. Participants' confidence in the health-care system was discovered to be a major indicator of their ability to use the COVID-19 vaccine. In response to the present situation, a low confidence in the health system could put community health at risk. The application of preventive health services like vaccination has been linked to a higher level of confidence in the health system. , This meta-analysis study has a number of limitations. Four articles seemed to be suitable for inclusion in this meta-analysis, but they lacked adequate evidence and had results that were insignificant for data estimation. This problem will exacerbate the risk of selection bias. The results show that health departments should implement urgent health promotion services and disseminate more reliable information. Governments should take action to ensure that people have enough information, have healthy attitudes, and have positive opinions about COVID-19 vaccines.

Conclusion

This study results showed the related factors for COVID-19 vaccination acceptance, high income has the highest odd ratio, followed by encountered with COVID-19, fear about COVID-19, perceived benefits, flu vaccine during the previous season, healtcare workers, male, married, perceived risk, trust in health system, chronic diseases, high education, high level of knowledge, female, and older age. The heterogeneity calculation showed homogenous among studies in low income, fear about COVID-19, healthcare workers, married, chronic diseases, and female. The findings of this study may help the government figure out the best way to implement COVID-19 mass vaccination programs.

Funding/ Financial Support

This study obtained no particular support from public, private, or non-profit funding agencies.
  43 in total

1.  Influenza vaccine--safe, effective, and mistrusted.

Authors:  Katherine M Harris; Jürgen Maurer; Arthur L Kellermann
Journal:  N Engl J Med       Date:  2010-11-24       Impact factor: 91.245

2.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

3.  Community awareness, use and preference for pandemic influenza vaccines in Pune, India.

Authors:  Neisha Sundaram; Vidula Purohit; Christian Schaetti; Abhay Kudale; Saju Joseph; Mitchell G Weiss
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey.

Authors:  Yogambigai Rajamoorthy; Alias Radam; Niazlin Mohd Taib; Khalid Ab Rahim; Subramaniam Munusamy; Abram Luther Wagner; Mudatsir Mudatsir; Abdullatif Bazrbachi; Harapan Harapan
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

5.  As the Pandemic Progresses, How Does Willingness to Vaccinate against COVID-19 Evolve?

Authors:  Stephanie J Alley; Robert Stanton; Matthew Browne; Quyen G To; Saman Khalesi; Susan L Williams; Tanya L Thwaite; Andrew S Fenning; Corneel Vandelanotte
Journal:  Int J Environ Res Public Health       Date:  2021-01-19       Impact factor: 3.390

6.  Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China.

Authors:  Yulan Lin; Zhijian Hu; Qinjian Zhao; Haridah Alias; Mahmoud Danaee; Li Ping Wong
Journal:  PLoS Negl Trop Dis       Date:  2020-12-17

7.  An interactive website tracking COVID-19 vaccine development.

Authors:  Madhumita Shrotri; Tui Swinnen; Beate Kampmann; Edward P K Parker
Journal:  Lancet Glob Health       Date:  2021-03-02       Impact factor: 26.763

8.  COVID-19 Vaccination Acceptance and Its Associated Factors Among a Middle Eastern Population.

Authors:  Walid A Al-Qerem; Anan S Jarab
Journal:  Front Public Health       Date:  2021-02-10

9.  COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey.

Authors:  Susan M Sherman; Louise E Smith; Julius Sim; Richard Amlôt; Megan Cutts; Hannah Dasch; G James Rubin; Nick Sevdalis
Journal:  Hum Vaccin Immunother       Date:  2020-11-26       Impact factor: 3.452

Review 10.  Neurological events related to influenza A (H1N1) pdm09.

Authors:  Graciela Cárdenas; José Luis Soto-Hernández; Alexandra Díaz-Alba; Yair Ugalde; Jorge Mérida-Puga; Marcos Rosetti; Edda Sciutto
Journal:  Influenza Other Respir Viruses       Date:  2014-05       Impact factor: 4.380

View more
  9 in total

1.  Influence of Information Sources on Chinese Parents Regarding COVID-19 Vaccination for Children: An Online Survey.

Authors:  Kai Li; Fen Zhou
Journal:  Int J Environ Res Public Health       Date:  2022-06-08       Impact factor: 4.614

2.  A Mapping Review on the Uptake of the COVID-19 Vaccine among Adults in Africa Using the 5A's Vaccine Taxonomy.

Authors:  Michael E Kalu; Oluwagbemiga Oyinlola; Michael C Ibekaku; Israel I Adandom; Anthony O Iwuagwu; Chigozie Ezulike; Ernest C Nwachukwu; Ekezie Uduonu
Journal:  Am J Trop Med Hyg       Date:  2022-05-09       Impact factor: 3.707

Review 3.  Parents' Decisions to Vaccinate Children against COVID-19: A Scoping Review.

Authors:  Fengming Pan; Hongyu Zhao; Stephen Nicholas; Elizabeth Maitland; Rugang Liu; Qingzhen Hou
Journal:  Vaccines (Basel)       Date:  2021-12-14

4.  The risk factors and pregnant women's willingness toward the SARS-CoV-2 vaccination in various countries: A systematic review and meta-analysis.

Authors:  Ricvan Dana Nindrea; Dovy Djanas; Ika Yulia Darma; Heni Hendriyani; Nissa Prima Sari
Journal:  Clin Epidemiol Glob Health       Date:  2022-02-10

5.  Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data.

Authors:  Chao Huang; Lijun Yang; Jia Pan; Xiaomei Xu; Rong Peng
Journal:  J Med Virol       Date:  2022-02-04       Impact factor: 20.693

6.  Knowledge, attitudes, perceptions, and COVID-19 hesitancy in a large public university in Mexico city during the early vaccination rollout.

Authors:  Norma Mongua-Rodríguez; Mauricio Rodríguez-Álvarez; Daniela De-la-Rosa-Zamboni; María Eugenia Jiménez-Corona; Martha Lucía Castañeda-Cediel; Guadalupe Miranda-Novales; Gustavo Cruz-Pacheco; Elizabeth Ferreira-Guerrero; Leticia Ferreyra-Reyes; Guadalupe Delgado-Sánchez; Maribel Martínez-Hernández; Arturo Cruz-Salgado; Rogelio Pérez-Padilla; Samuel Ponce-de-León; Lourdes García-García
Journal:  BMC Public Health       Date:  2022-10-04       Impact factor: 4.135

7.  COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis.

Authors:  Milad Azami; Marzieh Parizad Nasirkandy; Hadi Esmaeili Gouvarchin Ghaleh; Reza Ranjbar
Journal:  PLoS One       Date:  2022-09-28       Impact factor: 3.752

8.  Knowledge, attitude, and intention to accept COVID-19 vaccine among patients with chronic diseases in southern Ethiopia: Multi-center study.

Authors:  Getachew Asmare Adella; Kelemu Abebe; Natnael Atnafu; Gedion Asnake Azeze; Tamiru Alene; Simegn Molla; Gizachew Ambaw; Tekalign Amera; Amanuel Yosef; Kirubel Eshetu; Adisu Yeshambel; Dabere Nigatu; Endeshaw Chekol Abebe; Belete Birhan; Yibeltal Assefa
Journal:  Front Public Health       Date:  2022-09-29

Review 9.  COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis.

Authors:  Muhammad Mainuddin Patwary; Md Ashraful Alam; Mondira Bardhan; Asma Safia Disha; Md Zahidul Haque; Sharif Mutasim Billah; Md Pervez Kabir; Matthew H E M Browning; Md Mizanur Rahman; Ali Davod Parsa; Russell Kabir
Journal:  Vaccines (Basel)       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.